Showing results (1671-1680 of 1,852) with videos related to

Sort By:
Pageof 186
Gynecologic Oncology|March 26, 2017
A phase I pharmacokinetic study of intraperitoneal bortezomib and carboplatin in patients with persistent or recurrent ovarian cancer: An NRG Oncology/Gynecologic Oncology Group studyDanielle A Jandial, William E Brady, Stephen B Howell, et al.
Annals of the American Thoracic Society|August 29, 2018
Addressing Gender Inequality in Our Disciplines: Report from the Association of Pulmonary, Critical Care, and Sleep Division ChiefsCarey C Thomson, Kristin A Riekert, Carol K Bates, et al.
American Journal of Respiratory and Critical Care Medicine|July 18, 2022
Transcriptional Circuitry of NKX2-1 and SOX1 Defines an Unrecognized Lineage Subtype of Small-Cell Lung CancerRanran Kong, Ayushi S Patel, Takashi Sato, et al.
The New England Journal of Medicine|June 13, 2019
Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial CancerDaniela Matei, Virginia Filiaci, Marcus E Randall, et al.
The Science of the Total Environment|December 15, 2022
Vadose-zone alteration of metaschoepite and ceramic UO<sub>2</sub> in Savannah River Site field lysimetersConnaugh M Fallon, William R Bower, Brian A Powell, et al.
Gynecologic Oncology|September 12, 2024
Results of a randomized phase II trial of paclitaxel and carboplatin versus bleomycin, etoposide and cisplatin for newly diagnosed and recurrent Chemonaive stromal ovarian tumors: An NRG oncology/gynecologic oncology group study14Jubilee Brown, Austin Miller, Laura L Holman, et al.
Gynecologic Oncology|July 6, 2024
A toolkit for a modern gynecologic oncology tissue bankOlivia Graham, Jeimmy Rodriguez, Rachel Abbott, et al.
Journal of Environmental Radioactivity|September 18, 2023
Nuclear waste Educator's workshop: What and how do we teach about nuclear waste?Haruko Murakami Wainwright, Brian A Powell, Megan Elisabeth Hoover, et al.
The Oncologist|December 2, 2025
Characterization of the safety profile of trastuzumab deruxtecan by dose: a pooled analysis across DESTINY studiesYeon Hee Park, Javier Cortes, Shanu Modi, et al.
Molecular Cancer Therapeutics|May 19, 2022
GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell GlycolysisShaina F Bruce, Kevin Cho, Hollie Noia, et al.
Pageof 186